We would like to thank James Howard et al. for their insightful comments on our paper titled “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee.
February 3 – 7, 2025 – The Ritz Carlton Maui – Kapalua, Hawaii This course offers Live (in-person) and Livestream (virtual) attendance options. The Mayo…
Life expectancy in the United States varies by more than 20 years depending on race and ethnicity and where you live, according to new research.
ISTH is the leading international professional society on thrombosis and hemostasis. Listen to our podcast for the latest educational resources in our field.
1 Washington University School of Medicine in St. Louis, St. Louis, MO, United States 2 Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, United…
Access to effective antibiotics is essential to every health system in the world, however, antimicrobial resistance (AMR) threatens this backbone of modern medicine and is…
In newly diagnosed multiple myeloma (NDMM), measurable residual disease (MRD) status is prognostically important, but its role in treatment-decisions remains unclear. In a phase II…
Glioblastoma typically kills within 18 months, but a new type of treatment has kept Nadya El-Afandi’s scans clear 17 months after diagnosis.
An unexpected surge in lung cancer cases among nonsmoking women under 50 is raising alarms among oncologists, emphasizing the need for heightened awareness.
